Saturday 17 October 2026
Export APYX’s income statement to Excel — free account
Apyx Medical Corporation
APYX Healthcare Medical Devices
Apyx Medical Corporation’s revenue for fiscal 2025 (year ended December 2025) was $52.8 million, up 9.86% from fiscal 2024. In the quarter to June 2026, revenue grew 22.1%, EPS grew 22.2%, free cash flow fell 137.4% and total debt rose 2.74%, each against the same quarter a year earlier.
2.55
0.01
−0.39%
Follow APYX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 5 | 4 | 4 |
+8 more TTM periods Free account |
| (93.11%) | (77.27%) | (76.88%) | (168.32%) | ||
| (14.48%) | (14.89%) | (17.03%) | (24.63%) | ||
ROIC |
(11.76%) | (15.79%) | (22.44%) | (38.15%) | |
Return on Tangible Assets |
(18.81%) | (19.27%) | (22.81%) | (36.17%) | |
Average Days of Receivables |
85.07 | 83.28 | 115.87 | 99.02 | |
Free Cash Flow per Share |
(0.25) | (0.21) | (0.22) | (0.23) | |
Free Cash Flow |
(11.05) | (8.99) | (9.11) | (9.49) | |
Capital Expenditures |
(0.92) | (1.12) | (1.11) | (1.08) | |
| Other line items | |||||
Cash ROIC |
(14.92%) | (11.33%) | (11.19%) | (14.42%) | |
Accounts Receivable Turnover |
4.70 | 4.58 | 3.28 | 3.68 | |
Accounts Payable Turnover |
8.39 | 8.35 | 6.98 | 6.97 | |
Inventory Turnover |
2.25 | 2.39 | 2.45 | 1.97 | |
Average Days of Payables |
37.49 | 46.58 | 56.37 | 65.68 | |
Days of Inventory on Hand |
183.95 | 168.96 | 158.57 | 186.55 | |
Tax Rate |
0.06 | 0.04 | 0.02 | 0.02 | |
Research and Development Expense of Revenue |
5.65% | 5.96% | 6.38% | 7.40% | |
Selling, General and Administrative Expense of Revenue |
63.90% | 64.89% | 68.35% | 75.09% | |
Share Based Compensation of Revenue |
4.14% | 3.33% | 3.79% | 4.88% | |
Interest Coverage |
(0.63) | (0.77) | (1.15) | (1.63) | |
Operating CF/Net income |
1.17 | 0.86 | 0.71 | 0.58 | |
Depreciation/Fixed assets |
0.37 | 0.32 | 0.28 | 0.24 | |
Capex/Depreciation |
(1.17) | (1.56) | (1.70) | (1.88) | |
Revenue per Share |
1.33 | 1.28 | 1.29 | 1.18 | |
Operating CF per Share |
(0.23) | (0.18) | (0.19) | (0.21) | |
Capex per Share |
(0.02) | (0.03) | (0.03) | (0.03) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates